Fusion gene information | Fusion gene name: GRM5-RCBTB1 |
Fusion gene ID: hg2915tg55213 | | Hgene | Tgene | Gene symbol | GRM5 | RCBTB1 | Gene ID | 2915 | 55213 | Gene name | glutamate metabotropic receptor 5 | RCC1 and BTB domain containing protein 1 |
Synonyms | GPRC1E|MGLUR5|PPP1R86|mGlu5 | CLLD7|CLLL7|GLP|RDEOA |
Cytomap | ('GRM5')('RCBTB1') 11q14.2-q14.3 | 13q14.2 |
Type of gene | protein-coding | protein-coding |
Description | metabotropic glutamate receptor 5glutamate receptor, metabotropic 5protein phosphatase 1, regulatory subunit 86 | RCC1 and BTB domain-containing protein 1CLL deletion region gene 7 proteinGDP/GTP exchange factor (GEF)-like proteinchronic lymphocytic leukemia deletion region gene 7 proteinregulator of chromosome condensation (RCC1) and BTB (POZ) domain containing |
Modification date | 20200329 | 20200313 |
UniProtAcc | . | . |
Ensembl transtripts involved in fusion gene | ENST00000305432, ENST00000305447, ENST00000393294, ENST00000393297, ENST00000418177, ENST00000455756,
| |
Fusion gene scores | * DoF score | 9 X 9 X 2=162 | 6 X 6 X 2=72 |
# samples | 9 | 6 |
** MAII score | log2(9/162*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/72*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 |
Context | PubMed: GRM5 [Title/Abstract] AND RCBTB1 [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | GRM5(88422470)-RCBTB1(50106403), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GRM5 | C0036341 | Schizophrenia | 3 | PSYGENET |
Hgene | GRM5 | C0041696 | Unipolar Depression | 3 | PSYGENET |
Hgene | GRM5 | C1269683 | Major Depressive Disorder | 3 | PSYGENET |
Hgene | GRM5 | C0038220 | Status Epilepticus | 2 | CTD_human |
Hgene | GRM5 | C0041671 | Attention Deficit Disorder | 2 | CTD_human |
Hgene | GRM5 | C0270823 | Petit mal status | 2 | CTD_human |
Hgene | GRM5 | C0311335 | Grand Mal Status Epilepticus | 2 | CTD_human |
Hgene | GRM5 | C0393734 | Complex Partial Status Epilepticus | 2 | CTD_human |
Hgene | GRM5 | C0751522 | Status Epilepticus, Subclinical | 2 | CTD_human |
Hgene | GRM5 | C0751523 | Non-Convulsive Status Epilepticus | 2 | CTD_human |
Hgene | GRM5 | C0751524 | Simple Partial Status Epilepticus | 2 | CTD_human |
Hgene | GRM5 | C1263846 | Attention deficit hyperactivity disorder | 2 | CTD_human |
Hgene | GRM5 | C1321905 | Minimal Brain Dysfunction | 2 | CTD_human |
Hgene | GRM5 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Hgene | GRM5 | C0009171 | Cocaine Abuse | 1 | CTD_human |
Hgene | GRM5 | C0011882 | Diabetic Neuropathies | 1 | CTD_human |
Hgene | GRM5 | C0013146 | Drug abuse | 1 | CTD_human |
Hgene | GRM5 | C0013170 | Drug habituation | 1 | CTD_human |
Hgene | GRM5 | C0013222 | Drug Use Disorders | 1 | CTD_human |
Hgene | GRM5 | C0014556 | Epilepsy, Temporal Lobe | 1 | CTD_human |
Hgene | GRM5 | C0014558 | Uncinate Epilepsy | 1 | CTD_human |
Hgene | GRM5 | C0027796 | Neuralgia | 1 | CTD_human |
Hgene | GRM5 | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Hgene | GRM5 | C0038580 | Substance Dependence | 1 | CTD_human |
Hgene | GRM5 | C0038586 | Substance Use Disorders | 1 | CTD_human |
Hgene | GRM5 | C0038870 | Neuralgia, Supraorbital | 1 | CTD_human |
Hgene | GRM5 | C0042656 | Neuralgia, Vidian | 1 | CTD_human |
Hgene | GRM5 | C0234247 | Neuralgia, Atypical | 1 | CTD_human |
Hgene | GRM5 | C0234249 | Neuralgia, Stump | 1 | CTD_human |
Hgene | GRM5 | C0236736 | Cocaine-Related Disorders | 1 | CTD_human |
Hgene | GRM5 | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Hgene | GRM5 | C0271673 | Symmetric Diabetic Proximal Motor Neuropathy | 1 | CTD_human |
Hgene | GRM5 | C0271674 | Asymmetric Diabetic Proximal Motor Neuropathy | 1 | CTD_human |
Hgene | GRM5 | C0271678 | Diabetic Mononeuropathy | 1 | CTD_human |
Hgene | GRM5 | C0271680 | Diabetic Polyneuropathies | 1 | CTD_human |
Hgene | GRM5 | C0271685 | Diabetic Amyotrophy | 1 | CTD_human |
Hgene | GRM5 | C0271686 | Diabetic Autonomic Neuropathy | 1 | CTD_human |
Hgene | GRM5 | C0393672 | Epilepsy, Benign Psychomotor, Childhood | 1 | CTD_human |
Hgene | GRM5 | C0393682 | Epilepsy, Lateral Temporal | 1 | CTD_human |
Hgene | GRM5 | C0393835 | Diabetic Asymmetric Polyneuropathy | 1 | CTD_human |
Hgene | GRM5 | C0423711 | Neuralgia, Perineal | 1 | CTD_human |
Hgene | GRM5 | C0423712 | Neuralgia, Iliohypogastric Nerve | 1 | CTD_human |
Hgene | GRM5 | C0600427 | Cocaine Dependence | 1 | CTD_human |
Hgene | GRM5 | C0740858 | Substance abuse problem | 1 | CTD_human |
Hgene | GRM5 | C0751074 | Diabetic Neuralgia | 1 | CTD_human |
Hgene | GRM5 | C0751371 | Neuralgia, Ilioinguinal | 1 | CTD_human |
Hgene | GRM5 | C0751372 | Nerve Pain | 1 | CTD_human |
Hgene | GRM5 | C0751373 | Paroxysmal Nerve Pain | 1 | CTD_human |
Hgene | GRM5 | C1510472 | Drug Dependence | 1 | CTD_human |
Hgene | GRM5 | C4316881 | Prescription Drug Abuse | 1 | CTD_human |
Tgene | | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | | C0154832 | Exudative retinopathy | 1 | GENOMICS_ENGLAND |
Tgene | | C0339539 | Familial Exudative Vitreoretinopathy | 1 | GENOMICS_ENGLAND |
Tgene | | C1867332 | Reticular Dystrophy Of Retinal Pigment Epithelium | 1 | ORPHANET |
Tgene | | C4310680 | RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES | 1 | CTD_human;GENOMICS_ENGLAND;UNIPROT |